Clay B. Siegall

2007

In 2007, Clay B. Siegall earned a total compensation of $3.6M as President and CEO at Seattle Genetics, a 258% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$264,870
Option Awards$2,823,000
Salary$486,025
Other$5,365
Total$3,579,260

Siegall received $2.8M in option awards, accounting for 79% of the total pay in 2007.

Siegall also received $264.9K in non-equity incentive plan, $486K in salary and $5.4K in other compensation.

Rankings

In 2007, Clay B. Siegall's compensation ranked 1,223rd out of 8,700 executives tracked by ExecPay. In other words, Siegall earned more than 85.9% of executives.

ClassificationRankingPercentile
All
1,223
out of 8,700
86th
Division
Manufacturing
430
out of 3,314
87th
Major group
Chemicals And Allied Products
77
out of 746
90th
Industry group
Drugs
45
out of 546
92nd
Industry
Biological Products, Except Diagnostic Substances
10
out of 118
92nd
Source: SEC filing on April 9, 2010.

Siegall's colleagues

We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2007.

2007

Thomas Reynolds

Seattle Genetics

Chief Medical Officer

2007

Eric Dobmeier

Seattle Genetics

Chief Business Officer

2007

Todd Simpson

Seattle Genetics

Chief Financial Officer

2007

Morris Rosenberg

Seattle Genetics

EVP, Process Sciences

News

In-depth

You may also like